The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination-lessons learned from the SARS-CoV-2 pandemic

dc.contributor.authorBjarnarson, Stefanía P
dc.contributor.authorBrynjólfsson, Siggeir Fannar
dc.contributor.departmentFaculty of Medicine
dc.date.accessioned2025-11-20T09:12:21Z
dc.date.available2025-11-20T09:12:21Z
dc.date.issued2022-12-31
dc.description© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.en
dc.description.abstractThe importance of antibodies, particularly neutralizing antibodies, has been known for decades. When examining the immune responses against a pathogen after a vaccination or infection it is easier to measure the levels of antigen-specific antibodies than the T-cell response, but it does not give the whole picture. The levels of neutralizing antibodies are harder to determine but give a better indication of the quality of the antibody response. The induction of long-lived antibody-secreting plasma cells is crucial for a persistent humoral immune response, which has been shown for example after vaccination with the vaccinia vaccine, where antibody levels have been shown to persist for decades. With the SARS-CoV-2 pandemic ravaging the world for the past years and the monumental effort in designing and releasing novel vaccines against the virus, much effort has been put into analysing the quantity, quality, and persistence of antibody responses.en
dc.description.versionPeer revieweden
dc.format.extent10
dc.format.extent681927
dc.format.extent273-282
dc.identifier.citationBjarnarson, S P & Brynjólfsson, S F 2022, 'The role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination-lessons learned from the SARS-CoV-2 pandemic', Clinical and Experimental Immunology, vol. 210, no. 3, pp. 273-282. https://doi.org/10.1093/cei/uxac113en
dc.identifier.doi10.1093/cei/uxac113
dc.identifier.issn0009-9104
dc.identifier.other111058154
dc.identifier.othercb9ec662-53e7-4749-a5fb-b1a8aa0cd0e8
dc.identifier.other36480298
dc.identifier.otherPubMedCentral: PMC9985164
dc.identifier.other85149999365
dc.identifier.urihttps://hdl.handle.net/20.500.11815/7149
dc.language.isoen
dc.relation.ispartofseriesClinical and Experimental Immunology; 210(3)en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectHumansen
dc.subjectAntibody Formationen
dc.subjectSARS-CoV-2en
dc.subjectPandemicsen
dc.subjectAntibodies, Viralen
dc.subjectCOVID-19en
dc.subjectVaccinationen
dc.subjectAntigensen
dc.subjectAntibodies, Neutralizingen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleThe role of antigen availability during B cell induction and its effect on sustained memory and antibody production after infection and vaccination-lessons learned from the SARS-CoV-2 pandemicen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/articleen

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
uxac113.pdf
Stærð:
665.94 KB
Snið:
Adobe Portable Document Format

Undirflokkur